focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 16.00
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 2.00 (12.50%)
Open: 17.00
High: 17.00
Low: 17.00
Prev. Close: 17.00
GELN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First industrial production of 'Endure' battery

30 Sep 2022 07:00

RNS Number : 2601B
Gelion PLC
30 September 2022
 

30 September 2022

Gelion plc

("Gelion" or the "Company")

 

Gelion achieves a significant milestone with first industrial production of 'Endure' battery

 

Gelion (AIM: GELN), the Anglo-Australian battery storage innovator, today announces a significant milestone in delivering on its plans to take its non-lithium battery into industrial production.

 

Highlights

 

· Successfully established a pilot manufacturing plant at the lead-acid factory of its commercial partner Battery Energy Power Solutions Pty Ltd in Western Sydney, Australia.

· Pilot plant completed ahead of schedule with a 2MWh annual capacity. 

· Initial tests on the first batch of zinc-bromide batteries produced indicate that performance will meet current pilot customer requirements.

· The first battery production run will be exported to Acciona Energia in Spain, as announced in February 2022.

 

Gelion is now strongly positioned to deliver on its commercialisation strategy. This go-to-market strategy has come at a vital time as recent price rises of lithium batteries is driving customers and policy makers to seek alternative batteries, such as Gelion's zinc-bromide chemistry.

 

This Gelion pilot manufacturing plant is an end-to-end line with a repeatable manufacturing process, re-using more than 70% of the standard lead acid battery production processes. It provides a proven basis for the commercial scale up of Gelion's manufacturing capacity.

 

CEO Hannah McCaughey commented: "We are delighted to have reached the point of first industrial production of our breakthrough Endure battery proving that our unique and market leading battery can be produced at commercial levels with standard industrial processes in partnership with lead acid battery manufacturers. Our game changing technology is coming to market at the right time given the global energy crisis resulting in increased demand and an urgent need to find alternative solutions to the current incumbent technologies." 

 

First Commercial Production of Endure Battery

 

This is a significant step for Gelion as it moves from laboratory testing into scaled industrial production. Gelion's zinc-bromide battery is non-lithium with six to 12 hours of energy storage and is critical to deliver high penetration of renewables. The battery is designed to fit standard lead acid racks, which supports the Gelion industrial design process and leverages existing supply chains.

 

The battery storage system has been made from industrially produced cells and includes a Battery Management System (BMS) that will ensure extended battery life-time and service multiple applications, such as stand-alone power systems, grid stabilisation and renewable firming.

 

Acciona Energia Testing

 

Initial production at the new plant will be used in the Acciona Energia contract trial as announced in February 2022. The Acciona trial will be undertaken in two phases. Phase 1 includes the initial virtual simulation trial in October 2022 including battery testing, characterisation and in-field simulation. Phase 2 involves an onsite trial in Spain in May 2023. If the onsite trial is successful, the Endure battery will become part of Acciona's supplier portfolio as a renewable energy storage provider.

 

Further Potential Commercial Partnerships

 

Gelion has undertaken a significant amount of work in planning for the scaled-up production of Endure to meet growing customer demand. Furthermore, Gelion and Battery Energy Power Solutions is experiencing significant interest from companies in the energy, resource, mining as well as oil & gas sectors resulting in advanced discussions with various global players for trials, off-takes and partnerships.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION EU NO. 596/2014, AS RETAINED AND APPLICABLE IN THE UK PURSUANT TO S3 OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

CONTACTS

 

Gelion plc

Hannah McCaughey, CEO

Thomas Maschmeyer, Founder and Principal Technology Advisor

 

via Alma PR

finnCap Ltd (Nominated Adviser and Sole Broker)

+44 207 220 0500

Corporate Finance

Christopher Raggett

Seamus Fricker

Fergus Sullivan

 

ECM

Barney Hayward

 

Alma PR (Financial PR Adviser)

Justine James

Josh Royston

Hannah Campbell

Will Ellis Hancock

+44 20 3405 0205

gelion@almapr.co.uk

 

About Gelion plc

 

Gelion ("gel: ion") is a global renewable-energy storage innovator who supports the transition to a sustainable economy while delivering value for its customers and investors by designing and manufacturing the outstanding zinc-bromide batteries for stationary energy storage and additives for mobile battery applications.

 

Stationary storage - Gelion Endure: the sustainable energy storage solution

Gelion has developed patented technology for a breakthrough zinc-bromide battery to support the transition to a carbon neutral economy by 2050. The technology is a low-cost, robust, safe and recyclable alternative to lithium-ion and lead-acid batteries making them ideally suited for the expanding energy storage market.

 

Gelion's zinc-bromide gel battery uses non-flow technology, which is scalable, can deliver 100% depth of discharge and has a higher temperature tolerance and longer duration discharge than competing lead-acid and lithium-ion batteries. With applications at grid scale as well as behind the meter C&I, the battery solution is also highly adaptable for off-grid use.

 

Mobile storage - Tomorrow's transport systems will rely on mobile renewable energy.

Gelion is also developing performance additives to improve the safety, longevity and energy density of lithium-based batteries for mobile applications. Using nanotechnology, Gelion's lithium-silicon lithium-sulfur additives will help power the EV and e-aviation markets.

 

Gelion was spun-out from the University of Sydney in 2015 by Professor Thomas Maschmeyer, Fellow of the Australian Academy of Science and recipient of the Australian Prime Minister's Prize for Innovation 2020, that country's highest honour for scientific entrepreneurship.

 

The Company's ESG credentials are strongly aligned to six of the UN's 17 Sustainable Development Goals.

 

Gelion's shares are listed on the AIM market of the London Stock Exchange and it received the Green Economy Mark at IPO in November 2021 recognising its commitment to energy transition.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGZLMLZGZZZ
12
Date   Source Headline
24th Apr 20248:30 amRNSMello Investor Presentation
4th Apr 20247:00 amRNSLi-S Cell High Energy Density Milestone Achieved
27th Mar 20247:00 amRNSInterim results to 31 December 2023
20th Mar 202410:09 amRNSNotice of Results and Investor Presentation
19th Mar 20247:00 amRNSLithium-Sulfur Battery development update
5th Feb 20247:00 amRNSSenior Leadership Team Appointments
29th Jan 20247:00 amRNSBlock Admission Return
16th Jan 202411:27 amRNSResult of General Meeting
22nd Dec 202310:41 amRNSExercise of Options, Director Shareholding & TVRs
21st Dec 202312:23 pmRNSResult of AGM
14th Dec 20234:15 pmRNSPosting of Annual Report and Notice of GM
13th Dec 20237:00 amRNSDirector/PDMR Shareholding - Grant of options
12th Dec 202312:00 pmRNSFinal results to 30 June 2023
1st Dec 20237:00 amRNSDirector/PDMR Dealings and Total Voting Rights
30th Nov 202312:40 pmRNSHolding(s) in Company
29th Nov 20237:00 amRNSNotice of Results and AGM
27th Nov 20234:54 pmRNSResult of GM and Total Voting Rights
23rd Nov 20237:01 amRNSNotice of Investor Presentation
23rd Nov 20237:00 amRNSResult of Retail Offer and Total Voting Rights
21st Nov 20237:00 amRNSGelion and Ionblox JDA signed
9th Nov 20231:00 pmRNSResult of Placing and Posting of Circular
9th Nov 20238:00 amRNSUK Retail Offer
9th Nov 20237:17 amRNSProposed Acquisition, Placing, Retail Offer and GM
11th Oct 20237:00 amRNSExpanded Li-S R&D Facility launched
15th Aug 20237:00 amRNSTrading update and two new agreements signed
27th Jul 20239:45 amRNSBlock Admission Return
6th Jul 20237:00 amRNSZinc battery solution and Lithium Sulfur update
5th Jul 20237:00 amRNSChange of Registered Office
1st Jun 202312:05 pmRNSDirector/PDMR Shareholding
31st May 202312:15 pmRNSDirector/PDMR Shareholding
25th May 20237:19 amRNSStrategic progress on Johnson Matthey IP acq
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20239:15 amRNSDirector/PDMR Shareholding
17th Mar 202310:45 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim results to 31 December 2022
13th Mar 20237:00 amRNSLithium Sulfur IP Acq + Innovation Challenge
9th Mar 20237:00 amRNSAcq. of Johnson Matthey’s battery IP portfolio
1st Mar 20238:17 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSNotice of Results and Investor Presentation
27th Jan 20237:00 amRNSBlock Admission Return
16th Dec 202212:00 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSCEO Board Appointment and Grant of Options
9th Dec 202211:29 amRNSResult of AGM
6th Dec 20229:30 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSProof of performance additive viability
30th Nov 20229:50 amRNSDirector/PDMR Shareholding - Grant of options
24th Nov 202211:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:00 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20227:01 amRNSFinal results to 30 June 2022
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.